Concepedia

José Luís Calleja

JL

Statistics

Publications

182

Citations

15.4K

H-Index

68

Active since

1980

Affiliations

Hospital Universitario Puerta de Hierro Majadahonda(Current)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Hospital Clínic de Barcelona

Hospital Universitario Virgen del Rocío

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

José Luís Calleja is an author at Hospital Universitario Puerta de Hierro Majadahonda specializing in medicine, liver disease, and viral hepatitis.

ORCID

Publications per year

1980–2025

182

Publications

182

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

María Reig, Zoe Mariñó, Christie Perelló et al. · Journal of Hepatology · 2016 · 1K citations · Full text

, , +10

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Càndid Villanueva, Agustı́n Albillos, Joan Genescà et al. · The Lancet · 2019 · 671 citations

, , +8

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

George Papatheodoridis, George Ν. Dalekos, Vana Sypsa et al. · Journal of Hepatology · 2015 · 541 citations

, , +13

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Homie Razavi, Imam Waked, Christoph Sarrazin et al. · Journal of Viral Hepatitis · 2014 · 484 citations · Full text

, , +16

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

, , +12

1–5 of 182